AVATVSMRNA• 6 Months (Normalized)
AVAT vs MRNA (Avalanche Treasury Corporation vs Moderna Inc.)
Showing Closing Date Range from Mar, 15 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
AVAT Performance $1
-90.51%
Avalanche Treasury Corporation
Normalized Baseline0.00%
MRNA Performance $143.97
+170.06%
Moderna Inc.
Normalized Baseline0.00%
Alpha Spread Margin MRNA LEADS
-260.57%
MRNA outperforming by 260.57%
AVATMRNA
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
AVAT MRNA
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(125 dates)
| Date | AVAT Price | AVAT Gain (%) | MRNA Price | MRNA Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $1.00 | -90.51% | $143.97 | +170.06% | -260.57% |
| Sep 10, 2026 | $0.95 | -90.98% | $136.62 | +156.27% | -247.25% |
| Sep 09, 2026 | $0.96 | -90.91% | $135.61 | +154.38% | -245.29% |
| Sep 08, 2026 | $0.86 | -91.89% | $140.33 | +163.23% | -255.12% |
| Sep 04, 2026 | $0.75 | -92.91% | $145.55 | +173.03% | -265.94% |
| Sep 03, 2026 | $0.73 | -93.09% | $148.87 | +179.25% | -272.34% |
| Sep 02, 2026 | $0.72 | -93.16% | $150.81 | +182.89% | -276.05% |
| Sep 01, 2026 | $0.72 | -93.17% | $154.27 | +189.38% | -282.55% |
| Aug 31, 2026 | $0.72 | -93.13% | $140.34 | +163.25% | -256.38% |
| Aug 28, 2026 | $0.65 | -93.81% | $137.99 | +158.84% | -252.65% |
| Aug 27, 2026 | $0.63 | -94.07% | $142.77 | +167.81% | -261.88% |
| Aug 26, 2026 | $0.55 | -94.76% | $149.66 | +180.74% | -275.50% |
| Aug 25, 2026 | $0.52 | -95.11% | $158.83 | +197.94% | -293.05% |
| Aug 24, 2026 | $0.54 | -94.90% | $138.89 | +160.53% | -255.43% |
| Aug 21, 2026 | $0.49 | -95.35% | $145.13 | +172.24% | -267.59% |
Page 1 of 9